United States · FDA National Drug Code directory
Fluorouracil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-117_774fb5db-0103-4bf9-94d1-ca910ef934f1
- Product NDC
- 63323-117
- Form
- INJECTION, SOLUTION
- Composition / generic term
- FLUOROURACIL
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20000712
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUOROURACIL — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-117-58) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE · 63323-117-58
- 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-117-68) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE · 63323-117-68
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →